Foreign drug manufacturers call for simpler price assessment procedures over new drugs

Published: 2009-04-20 07:00:00

Updated: 2009-04-20 07:00:00

Representatives from the Korean Research-based Pharmaceutical Industry Association (KRPIA) said on April 15 that the Korean government will have to overhaul the current positive list system by incorporating the screening process of new drugs eligible for national health insurance reimbursement with their price negotiation process.

In a brief session with the Health Insurance Review and Asses...

Fees

- Email service daily and homepage access.

$300 per month.
5 Email holders per each company.
Anual contract base.